This review will summarize the distinct phenotypes of HDM-driven asthma, emphasize the importance of confirming the clinical relevance of immunoglobulin (Ig)E sensitizations, and discuss the many benefits associated with HDM immunotherapy in critical asthma outcomes. Here, IGHE is linked to asthma.